Results 251 to 260 of about 213,329 (290)

Human CMV vaccine trials: What if CMV caused a rash?

Journal of Clinical Virology, 2008
There are no apparent biologic obstacles to immunization against fetal/placental infection with cytomegalovirus (CMV), and vaccine candidates have been developed. The major obstacles for a human CMV vaccine are difficulties associated with the design and execution of efficacy trials.
openaire   +2 more sources

Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation

Cellular and Molecular Immunology, 2022
Meng Lv, Xiaosu Zhao, Lan-Ping Xu
exaly  

DIAGNOSIS OF CMV

The Pediatric Infectious Disease Journal, 1999
openaire   +2 more sources

CMV

2006
  +4 more sources

Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study

Clinical Infectious Diseases, 2020
Dimpy P Shāh, Sherif Mossad, Scott Rowley   +2 more
exaly  

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity

Open Forum Infectious Diseases, 2021
Raymund Razonable, Apirom Vongsakulyanon, Jackrapong Bruminhent   +2 more
exaly  

Immunologic Monitoring after Allogeneic Stem Cell Transplantation: T-SPOT.CMV and QuantiFERON-CMV, Are They the Same?

Transplantation and Cellular Therapy, 2023
Elizaveta Padalko, Sofie Colman, Marijke Reynders   +2 more
exaly  

Linking CMV Serostatus to Episodes of CMV Reactivation Following Lung Transplantation by Measuring CMV-Specifi cCD8+ T-Cell Immunity

American Journal of Transplantation, 2008
Nicole Andrea Mifsud
exaly  

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality

Clinical Microbiology and Infection, 2015
Hongguang Chen, C H Yan, Y J Chang
exaly  

CMV

2012
Shannon A. Ross, Suresh B. Boppana
openaire   +1 more source